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Abstract

A 39 kDa outer membrane protein ( O M P ) w a s extracted and purified from
Actinobacillus pleuropneumoniae serovar 1 (HS54), 7 (WF83) and 12 (HS143).
The 39 kDa O M P of all three serovars showed strong immunoreactivity against
sera from pigs challenged with A. pleuropneumoniae serovars 1, 7 and 12.
Furthermore, the 39 kDa O M P from serovar 1, when used as an ELISA antigen
showed strong immunoreactivity against sera from pigs that were infected with
various A. pleuropneumoniae serotypes. This result suggests that the 39 kDa
O M P m a y be used as an ELISA antigen to detect A. pleuropneumoniae
regardless of the infecting serotype.

Actinobacillus pleuropneumoniae is known to produce three members of the
repeat in toxin (RTX) family of toxins, which include, Apxl, Apxll and Apxlll.
Recently, a fourth R T X toxin has been identified (ApxIV), cloned, and the Nterminal (N-apxIV) and C-terminal (C-apxIV) domains expressed. W e were able
to purify and assess the immunoreactivity of the recombinant ApxIV domains.
Recombinant C-apxIV was observed to be more immunoreactive than
recombinant N-apxIV when used as ELISA antigen. In an ELISA assay involving
hemolysin (Apxl) toxin along with the recombinant C-apxIV and N-apxIV, sera
from pigs infected with A. pleuropneumoniae recognized all three toxins.
However, the immunoreactivity w a s significantly different for the recombinant
ApxIV toxin domains compared to that of Apxl. Apxl showed significantly stronger
reactivity at all stages of infection. This result suggests that further work is
needed to confirm whether the recombinant ApxIV toxin domains can be used as
ELISA reagents in the detection of A. pleuropneumoniae during the course of an
infection.
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Chapter 1: Introduction
1.1 Family Pasteurellaceae

The family Pasteurellaceae includes the genera Haemophilus, Actinobacillus and
Pasteurella. The members of this family were initially recognized because of the
clinical conditions they caused in host animals (Zinnemann, 1981). They were then
recognized on the basis of their morphology, their ecology (host range and
disease) and biochemical tests (Mannheim, 1984). Later on, the organisms were
assigned to the family Pasteurellaceae primarily on their requirement for the growth
factors hemin and N A D .

Phenotypic classification was based on numerical taxonomy, which examined large
(>150) numbers of strains using a large number of phenotypic tests (>150) and
similarities based on the results of these tests were measured. At best, the
approach could be used to look at only 10-20% of the genome. The different ways
in which similarity co-efficients were utilized to estimate resemblance m a d e it
difficult to accurately phenotype these bacteria (Austin and Priest, 1986) In the
1980s, a concerted effort was made to examine the genotypic properties of the
members of this family, moving away from the phenotypic characteristics. S o m e of
the current taxonomic methods used to classify Haemophilus, Actinobacillus and
Pasteurellaceae (HAP) include chemotaxonomy (analysis of composition of cell
walls), protein analysis (polypeptide fingerprinting), % G + C determination, D N A
analysis, rRNA analysis and to a lesser extent genetic transformation and analysis
of quinones (Maclnnes and Borr, 1990).

According to the latest edition of Bergey's Manual of Systemic Bacteriology (19
there are 27 approved species in the H A P group. There are 16 in the Genus
Haemophilus, five in the Genus Actinobacillus, and six in the Genus Pasteurella
(table 1) (Mannheim, W., 1984).
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Table 1.1. Members of the H A P family (adapted from Bergey's manual, 1984)
Haemophilus

Actinobacillus

1. H. influenzae

1. A. lignieresii

1. P. multocida

2. H. aegyptius

2. A. equuli

2. P. pneumotropica

3. H. haemolyticus

3. A. suis

3. P. haemolytica

4. H. haemoglobinophilus

4. A. capsulatus

4. P. ureae

5. H. ducreyi

5. A. actinomycetemcomitans 5. P. gallinarum

I Pasteurellaceae

6. H. parainfluenzae
7. H. parahaemolyticus
8. H. paraphrohaemolyticus
9. H. pleuropneumoniae
10.H. paracuniculus
11. H. aphrophilus
12.H. paraphrophilus
13.H. segnis
14.H. parasuis
15.H. parragallinarum
16.H. avium
a) "H. somnus" (subcategorization of H.
avium)
b) "H. agni" (subcategorization ofH.
avium)
c) "H. equigenitalis" (subcategorization of H.
avium)
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1.2Actinobacillus pleuropneumoniae
Actinobacillus pleuropneumoniae is a facultative, anaerobic, non-motile Gramnegative coccobacillus within the H A P family. A. pleuropneumoniae is the etiologic
agent of swine pleuropneumonia (Nicolet, 1992). Before 1983, this organism was
known as Haemophilus pleuropneumoniae. However, its similarity with
Actinobacillus lignieressie and not Haemophilus influenzae in D N A hybridization
studies led to the transfer of this organism to the Genus Actinobacillus (Pohl et al.,
1983). A. pleuropneumoniae has been classified into two biotypes. Biotype 1
strains are nicotamide adenine dinucleotide (NAD) dependent while biotype 2
strains on the other hand, are NAD-independent (Haesebrouck et al., 1997). A.
pleuropneumoniae is known to have 14 serotypes, based on capsular antigens.
There are 12 serotypes within biotype 1 (Nielsen, 1986) and 2 within biotype 2
(Fodor et al., 1989). Serotypes 1 and 5 are further subdivided into 1a and 1b and
5a and 5b respectively (Jolie et al., 1997). The first report of A. pleuropneumoniae
in Australia was in N e w South Wales in 1974 (Mylrea et al., 1974). Serovar 1 is
most c o m m o n in Victoria, while serovar 7 is found commonly in N e w South Wales,
Queensland, and Victoria. Serovar 12 has been isolated in N e w South Wales,
Queensland, Victoria, and South Australia (Blackall and Pahoff, 1995).
1.3Swine pleuropneumonia
Swine pleuropneumonia is a severe lung disease in pigs caused mainly by A.
pleuropneumoniae (Nicolet and Scholl., 1981). This disease is characterized by
necrotizing hemorrhagic bronchopneumonia with accompanying fibrinous pleuritis
(Nicolet etal., 1992). Acute pleuropneumonia is characterized by fibrinous
adhesion caused by A. pleuropneumoniae in the pleural cavity accompanied by
necrotic and hemorrhagic lesions in the lungs, leading to death in 24 to 48 hours
following infection (Haesebrouck etal., 1997). Acute pleuropneumonia causes
high mortality in non-immune pigs. The chronic form of the disease, which does not
result in immediate death, does cause economic losses due to poor weight gain by
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infected pigs and failure to thrive (Inzana et al., 1991). D u e to these reasons, A.
pleuropneumoniae

is considered a threat to the pig industry (Pointon et al., 1995).

1.4Virulence factors

A. pleuropneumoniae, as well as other pathogenic bacteria in the family
Pasteurellaceae are generally characterized by their ability to (i) colonize mucosal
surfaces (ii) invade host tissues, (iii) survive and multiply in the host, (iv) interfere
with host defenses, and eventually (v) d a m a g e the host (Nicolet, 1990). T h e
bacterium possesses adhesion structures, capsular polysaccharides, surface
structures such as outer m e m b r a n e proteins ( O M P s ) , lipopolysaccharides (LPS)
and secrete extracellular toxin products, a m o n g t h e m exotoxins, in order to help
the bacterium infect host animals and in m a n y cases, cause disease (Table 1.2).
Not all A. pleuropneumoniae serotypes are equally pathogenic. The virulence of A.
pleuropneumoniae

is different across serotypes. In general, biotype 1 is m o r e

virulent than biotype 2. Within biotype 1 group, serovars 1a, 1b, 5a, 5b, 9 and 10
are considered most virulent (Haesebrouck et al., 1997).
Table 1.2. S u m m a r y of H A P family virulence factors, and i m m u n e protection with
antibodies (modified from W a n n e m e u h l e r et al., 1994).
Cellular c o m p o n e n t

Role in disease

Capsule

Antiphagocytic, inhibition of complement activation

Endotoxin

Pyrogenicity, toxicity

Pili

Cell adhesion

Outer m e m b r a n e

Antigenic variation, nutrient acquisition

proteins ( O M P s )
Exotoxin

Cell death, fluid secretion

Cytoplasmic

Nutrient acquisition, adherence

m e m b r a n e and
cytosolic proteins
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1.4.1 Capsule

Within the H A P group, the presence of the polysaccharide capsule is a c o m m o n
feature. The encapsulated pathogens in the H A P family are H. influenzae, A.
pleuropneumoniae, P. haemolytica and P. multocida (Nicolet, 1990). Bacteria that
are encapsulated can be divided into different serotypes based on structural and
antigenic differences in the capsule. In m a n y cases, serotypes can be
differentiated into subtypes based on differences within somatic antigens (Inzana,
1991).
The capsule surrounds the outer membrane of the cell. These can be observed by
light microscopy. Each of the capsules of the Pasteurellaceae that have been
purified and analyzed are acidic, of high molecular weight and heterogeneous
polysaccharides. The polysaccharide capsules are composed of repeating units of
two or three sugars or aminosugars. Also present are glycerol, acetyl phosphate,
carboxyl and uronic acid groups. Phosphate groups or uronic acid provide the
negative charge on the capsule (Inzana, 1991).
Capsule is a required virulence factor in A. pleuropneumoniae pathogenesis
because its presence prevents opsonization and clearance of bacteria in the lungs
of the host (Inzana, 1991). Capsular polysaccharides can inhibit phagocytosis,
mask underlying antigens from antibodies and prevent activation of complement
(Wannemuehler et al., 1994). Although the actual mechanism of resistance to
killing by antibodies is not very clear, indications are that encapsulation of the
pathogen interferes with deposition of the m e m b r a n e attack complex of
complement.

The serotype specificity of A. pleuropneumoniae is due to the presence of capsu
antigens (Fedorka-Cray et al., 1994). The differences in virulence between
different serotypes or even within the s a m e serotype have also been attributed to
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the structure of the capsule of the A. pleuropneumoniae serotypes (Jensen ef a/.,
1986).
1.4.2 Adhesins

The ability of most pathogenic bacteria to induce disease depends in their abil
adhere to epithelial cells. During the initial step of pathogenesis, bacteria colonize
host sites by engaging their surface bound adhesins with cognate receptors
available on host cells. This recognition and attachment process is considered to
be the first steps in establishing bacteria at a given site. It has been proposed that
A. pleuropneumoniae adheres to lower respiratory epithelial cells, possibly leading
to a local high concentration of Apx toxins at the surface of those eukaryotic cells.
Haemagglutination as well as in vitro adherence of the pathogen to porcine
tracheal epithelial cells, frozen lung cells, and mucus of the respiratory tract have
also been reported (Haesebrouck et al., 1997). The role for fimbrae in the adhesion
of A. pleuropneumoniae has not been demonstrated although they have been
detected in this organism (Dom et al., 1994).
1.4.3 Outer membrane proteins (OMPs)
Outer membrane proteins are considered to be important in regulation of surface
proteins in response to environmental growth conditions. Across the H A P family,
O M P s seem to play various roles in pathogenicity of the bacteria. S o m e of these
proteins have been found to induce the synthesis of protective serum antibodies to
P. haemolytica (Mosier ef al., 1989), as well as A. pleuropneumoniae (Maclnnes
and Rosendal, 1987). The best-characterized O M P s with immunoprotective
properties are the P2 and P 6 porins of H. influenzae and the protein H of P.
multicoda. Although the exact biological mechanisms of these proteins are not
known, evidence of the participation of O M P s in virulence is furnished by an O M P
with antiphagocytic activity in P. multicoda. A. pleuropneumoniae is able to
synthesize I R O M P S (iron regulated O M P s ) with receptor functions for complexed
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iron, indicating the role of O M P s in the adaptability of the bacterial cell to the host
environment (Deneeref al., 1989).
Certain outer membrane proteins have been identified in A. pleuropneumoniae
which are conserved across serovars, unlike serotype dependent
lipopolysaccharides which are the preferred antigens in A. pleuropneumoniae
detection systems. All serovars express several c o m m o n outer membrane
proteins, including the peptidoglycan associated lipoprotein PalA (14 kDa), a
protein that varies from 38-42 kDa and a 48 kDa protein (Frey et al., 1996).
Immunologically, PalA, the 32 kDa and the 39 kDa protein are found to be
immunodominant, based on immunoreactivity studies (Frey et al., 1996; Jansen,
1994; Maclnnes and Rosendal, 1987). It has been shown that convalescent phase
sera from A. pleuropneumoniae infected pigs contain antibodies against these
proteins and s o m e other O M P s (Cruz et al., 1996). S o m e of the immunodominant
O M P s of A. pleuropneumoniae have been cloned and expressed to be used as
potential antigens for vaccine/diagnostic purposes. These include the 48 kDa O M P
of serotypel and serotype 5, and a 16 kDa O M P of serotype 5 (Gerlach et al.,
1993; Bunka etal., 1995; Cruz etal., 1996).

1.4.4 Lipopolysaccharides (LPS)

LPS are high molecular weight molecules that form part of the outer membranes o
Gram-negative bacteria. L P S are comprised of a complex lipid material and are
involved in the release of proinflammatory mediators that activate various cells,
including macrophages and neutrophils. In the H A P group of bacteria, L P S have
been implicated as major factors in the pathogenesis of disease caused by
members of this group. This is due to its prominence as a surface component of
the pathogen and ability to cause tissue damage.

Structurally, liposaccharides are high molecular weight complex macromolecules
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which are an integral component of the outer m e m b r a n e of Gram-negative
bacteria. Although the basic structure of L P S is similar in all Gram-negative
bacteria, there are variations in terms of outer saccharides. The polysaccharide
portion of the L P S is divided into two regions. The outer region (O-antigen) is
comprised of repeating oligosaccharide chains of various lengths. It is the vast
number of potential constituents and variable linkages that provide the O- antigens
with antigenic specificity. While capsular polysaccharides form the basis of the
serotype differentiation of H A P group bacteria, O-antigens are important in s o m e
cases (Fenwick, 1990). The inner region of L P S is less variable both structurally
and antigenically.
The Haemophilus species appear to be unique among the HAP group of bacteria
in that their liposaccharides lack polymerized O-antigen. The term
lipooligosaccharides has b e c o m e standard w h e n referring to the liposaccharides of
Haemophilus species. The structural, and thus antigenic, variability of the
saccharide portion of the LPS, probably allows it to play a role in helping the
bacterium avoid antigen-specific immune responses. T h e major contribution of L P S
to virulence is its ability to activate non-specific host defenses. The ability of L P S to
trigger host defence system rests in the lipid portion of the molecule.
Lipopolysaccharides m a y work together with exotoxins in mediating the disease
process (Fedorka-Cray et al., 1994). It has been reported that purified A.
pleuropneumoniae

L P S has the potential to cause tissue damage. In that study,

the lesions induced by A. pleuropneumoniae

L P S in pig lungs were neither

haemmorhagic nor necrotic, indicating that L P S is not responsible for the typical
A.pleuropneumoniae lesions. It may, however, contribute to the formation of such
lesions (Haesebrouck et al., 1997).
1.4.5 Exotoxins

Exotoxins are extracellular soluble proteins actively released by live organisms tha
play a major role in evasion of the hosts' first line of defence. The repeat in toxin

8

(RTX) family of toxins, w h e n present in high concentrations, form pores in
membranes of phagocytic and other target cells resulting in osmotic swelling and
cell death. They might also be involved in development of lesions in lungs, toxicity
for endothelial cells and provoke an oxidative burst in macrophages and
neutrophils, resulting in excessive production of oxygen radicals which can have
deleterious effects on host cells (Haesebrouck et al., 1997).

acylACP carrier protein . . _
HlyC acyl transferase

Hydrophobic
pore-forming
177-411

\

K690

G-repeats
Glycine rich Ca-binding
repeats

Lysine residues at 564 and 690 are acylated - active HlyA

Fig 1.1. Basic structure of Apxl (hemolysin) R T X toxin. Toxins of the R T X family contain a
hydrophobic pore forming region in the N terminus (in red), a glycine repeat region in the C
terminus (purple) and a middle region containing lysine residues (yellow). Activation of the toxin
involves acylation of the lysine residues at positions 564 and 690 by co-synthesized HlyC which is a
homodimeric putative acyltransferase that uses acyl-acyl earner protein (acyl-ACP) as the fatty acid
donor to the lysine residues (Stanley, 1994).

In A. pleuropneumoniae, three protein toxins have been identified, which fall in the
category of R T X family of toxins. These possess hemolytic and neutrophil toxic
(cytotoxic) activity (Frey, 1995). R T X toxin family is distinguished by a strongly
hydrophobic domain in the N terminal, which is involved in the insertion of the toxin
molecule into the target host cell (fig. 1.1). There is a glycine repeat region in the
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C-terminal which is believed to be involved in calcium binding required for target
cell recognition and binding. Lysine residues in the middle region of the toxin
operon are considered important in the activation of the toxin. Acylation of the
lysine residues by acyl transferase activates inactive prohemolysin into active
hemolysin (Stanley, 1998) (fig. 1.2). R T X family of toxins includes hemolysin from
E. coli, leukotoxins of Pasteurella and Actinobacillus, and the adenylate cyclasehemolysin of Bordetella pertussis.

RfaH (+)

Fig. 1.2. Hemolysin synthesis, maturation, and export by E. coli and other related Gram-negative
bacteria including A. pleuropneumoniae. The hemolysin gene encodes inactive pro-hemolysin
(proA), which is activated by HlyC with the help of carrier protein (acylACP). (CM, cytoplasmic
membrane; O M , outer membrane; acylACP, acyl- Acyl Carrier Protein; RfaH, elongation protein
[adapted from Stanley etal., 1998].

A. pleuropneumoniae produces three toxins, designated Apxl, Apxll and Apxlll.
Nucleotide sequence analysis of the Apxl-, Apxll-, and Apxlll-coding genes have
demonstrated that these toxins are closely related m e m b e r s of the R T X toxin
family. R T X toxins are encoded by operons that consist of four contiguous genes,
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C, A, B, and D. The A gene encodes the structural toxin that is activated by the C
gene encoded protein. The B and D gene-encoded proteins are involved in the
secretion of the RTX-toxins (Holland etal., 1990). All three Apx toxins strongly
resemble each other but differ in size, function and presence in A.
pleuropneumoniae. Not all serotypes of A. pleuropneumoniae produce the same
combination of the toxins, and spontaneous loss of toxin production is known to
occur (Anderson etal., 1991).
apxl

apxll

apxlll

serotypes 1, 5a/b, 9,11

C

A

B

D

C

A

Serotypes 2,4,6,8

B

D

_

._, ......

C

A

C

A

B

D

C

A

C

A

B

D

C

A

Serotype 3

Serotypes 7,12

B

D

Serotype 10

C

A

B

D

Fig 1.3. Operons of Apxl, Apxll Apx III in A. pleuropneumoniae. White boxes represent genes of the
apxl operon; Yellow boxes represent genes of the apxll operon; red boxes represent genes of the
apxlll operon. Half boxes represent 5'- terminal truncated apxIA (white) or 3'- terminal truncated
apxIB (yellow) genes [adapted from Beck etal., 1994].
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1.4.5.1 Apxl

Apxl, is a R T X toxin with an apparent molecular mass of 105 kDa to 110 kDa. It is
considered strongly hemolytic and strongly cytotoxic to pig alveolar macrophages
and neutrophils. Apxl is produced and secreted by serotypes 1, 5a, 5b, 9, 10 and
11 (Beck et al., 1994). However, sequences homologous to the secretion genes
apxIBD of the Apxl operon are present in all 12 serotypes except serotype 3
(Jansen et al., 1993). Structural analysis of the Apxl operon has revealed that
serotypes 1, 5, 9,10 and 11 contain the four genes apxICABD. Apxl operons with a
major deletion in the apxICA gene are present in serotypes 2, 4, 6, 7, 8 and 12 (fig.
1.3). All Apxl operons are transcriptionally active despite the partial deletion of the
operon in some serotypes (Jansen etal., 1993).
1.4.5.2 Apxll
Apxll is another RTX toxin produced by A. pleuropneumoniae with an apparent
molecular weight between 103-105 kDa. Unlike Apxl, this toxin is weakly hemolytic
and moderately cytotoxic. All serotypes except serotype 10 produce Apxll (fig.1.3)
(Kamp et al., 1991). The secretion of the toxin differs across serotypes. While it is
secreted in growth medium by serotypes 1, 2, 4-9,11 and 12, in serotype 3, Apxll is
not secreted (Frey, 1995). Secretion of Apxll may occur through the products of
the apxl operon as genes encoding protein secretion have not been found in the
apxll operon (Frey etal., 1993).
1.4.5.3 Apxlll

Apxlll is the third RTX toxin produced by A. pleuropneumoniae. It has an appare
molecular weight of 120 kDa. It is not hemolytic but strongly cytotoxic for alveolar
macrophages and neutrophils. Apxlll is produced and secreted by reference
strains of serotype 2, 3,4, 6 and 8 (Kamp et al., 1991). Sequence analysis of
ApxIIICABD genes of all serotypes reveals very few serotype specific differences.
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Only the C-terminus of ApxIIIA of serotype 2 differs from ApxIIIA of the other
serotypes (Jansen et al., 1994). Those differences are located between the
glycine-rich repeats and the secretion signal.
1.4.5.4 ApxIV

Recently a fourth RTX toxin determinant has been characterized (Schaller et al.,
1999). Anderson and McGuinnes (1997) reported the identification and cloning of a
lacZ analogue in A. pleuropneumoniae. Sequence information revealed the
presence of a R T X toxin downstream. Using this information, Schaller and
colleagues designed primers and cloned this toxin, designating it ApxIV. The
function of the toxin has not been established yet. ApxIV is claimed by Schaller and
colleagues (1999) to be expressed by A. pleuropneumoniae in pigs during the
course of infection only and has not been expressed in vitro to date (Table 1.3).
Table 1.3. S u m m a r y of Apx toxins of A. pleuropneumoniae
R T X toxin

M W size

Function

Serovars

Reference

Apxl

105 kDa

Strongly

1,5,9.10,11

Beck etal, 1994

All except 10

K a m p et al,

hemolytic;
Strongly
cytotoxic
Apxll

105 kDa

Weakly

1991

hemolytic;
Moderately
cytotoxic
Apxlll

120 kDa

Non hemolytic;

2,3,4,6,8

Macdonald et
al., 1992

Strongly
cytotoxic
ApxIV

202 kDa
(predicted)

unknown

All serovars

Schaller et al.,
1999
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1.5 Diagnosis of pleuropneumonia

1.5.1 Clinical and pathologic diagnosis

A typical outbreak of pleuropneumonia caused by A. pleuropneumoniae can have
a morbidity of 5 0 % or higher, with 1 % - 1 0 % mortality. Young pigs are usually the
most affected, and thefirstsigns of the disease include stiffness, lameness,
anorexia, lethargy, and fever. Clinical signs of a respiratory nature develop soon
after, and are characterized by shallow inspiratory volumes, deep non-productive
cough as well as marked abdominal pushes.
According to Nicolet and Scholl (1981), swine pleuropneumonia can be classified
into four stages. The initial stages include the paracute and acute stages. During
the paracute stage of the disease, pigs become very ill with 106.7°C fever, and
showing apathy and anorexia, followed by a short period of diarrhea and vomiting.
Death occurs within 24-36 hours. The acute stage is characterized by a rise in the
body temperature to 105°C-106°C, with pigs showing signs of depression and
refusing to eat. Respiratory symptoms with dysprea, coughing and sometimes
mouth-breathing are evident. The course of disease can differ within animals,
leading to the next stages of subacute, acute or resulting in death. The subacute
and chronic symptoms follow after the disappearance of the acute symptoms.
Clinical signs include absence of fever, spontaneous or intermittent cough, loss of
appetite, and therefore decrease weight gain. Abortions by pregnant sows have
been observed in s o m e chronic cases.

It has been suggested that clinical signs are not good indicators of the amount of
lung d a m a g e (Straw etal., 1990). Due to the rapid progression of this disease, a
quick, accurate diagnosis is required in order to initiate treatment.
Diagnosing an acute outbreak of pleuropneumonia is much easier than diagnosing
subclinical disease. Slaughter checks are one w a y to diagnose the infection but in
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cases where acute lesions are absent, this type of diagnosis is useless, as
slaughter checks won't yield any results. In m a n y cases, even the severe
pulmonary lesions induced by A. pleuropneumoniae resolve in a few weeks (Noyes
etal., 1990).

1.5.2 Microbiological diagnosis

The HAP family of bacteria of veterinary importance has certain similar attribute
and includes the types of disease they cause, routes of transmission, virulence
factors and antigens believed to be responsible for providing protective immunity.
In the case of A. pleuropneumoniae, accurate identification is possible by culture
on blood agar and the evidence of small waxy to mucoid colonies that satellite
around a Staphylococci cross-streak. Incubation in 5 to 7 % concentration of C 0 2
aids in initial isolation. A positive urease reaction is an important clue in identifying
A. pleuropneumoniae. However, biotype 2 which does not require N A D and s o m e
strains that are urease negative, can lead to misidentification of this pathogen
(Frank et al., 1992; Blanchard et al., 1993). Technologies such as the use of
specific D N A probes and polymerase chain reaction provide powerful new methods
of confirming an isolate's identity (Sirois etal., 1991).

1.5.3 Serological diagnosis
Over the years, numerous serologic tests have been developed, some of which are
currently in use. The complementfixation(CF) test has been the serodiagnosis
standard, but during the past few years, its value has been questioned. The reason
for this is because the C F test relies heavily on IgM antibodies and as the time
between infection and testing increases, the test becomes less reliable. Also, since
C F tests detect antibodies to surface antigens, they m a y fail to detect pigs infected
with untypable A. pleuropneumoniae strains. A s a result, C F tests have few false-
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positive results, but high false-negative results compared to other serological tests.
O n e other disadvantage of the test is that this test cannot resolve the problem of
pro-complementary and anti-complementary activity of s o m e swine sera
(Gottschalk, 1994). Even then, C F tests have been valuable in porcine
pleuropneumonia control programs. The fact is that even a few C F positive test
results are taken as evidence that the herd is infected with A. pleuropneumoniae
(Fenwick, 1990).
Enzyme Linked Immunosorbent Assay (ELISA) is used to detect antibodies against
A. pleuropneumoniae. The most c o m m o n ELISA tests are based on either direct
interaction of pig sera with A. pleuropneumoniae antigens or on the inhibition of
polyclonal rabbit sera by pig sera samples. Most c o m m o n antigens include L P S
and capsular polysaccharide (CPS), which are again, serovar specific. Antibodies
against these can have cross reactivity problems with L P S and C P S from other
bacterial strains such as E. coli in an indirect ELISA due to overlapping epitopes.
Subsequently, the chances of cross reactivity m a y be greater w h e n polyclonal
antibodies are used in an inhibition ELISA or if LPS/CPS are the antigens in an
indirect ELISA. In contrast to C F tests, ELISA tends to overestimate the
prevalence of the disease due to a higher frequency of false positive results.

Cytotoxin neutralization tests detect resistance to important virulence factors an
current vaccines do not affect results obtained using this method. Vaccines can
cause pigs to test positive by complement fixation testing as well as ELISA. The
disadvantage of cytotoxin neutralization tests is that they are complicated to
perform and are more expensive (Fenwick, 1990).

1.6 Purpose of the research project

Actinobacillus pleuropneumoniae is the etiologic agent of porcine
pleuropneumonia. The presence of this disease, whether in the chronic form or in
the acute form, causes major loss to the pig industry. In Australia, the acute form of
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this disease has resulted in major losses to the pig industry. Swine
pleuropneumonia continues to be a problem in Australia and elsewhere. O n e of the
reasons for this is because there are no tests available that use a "common"
antigen that can be used in the detection of A. pleuropneumoniae, regardless of
the serovar, during the course of an infection.
Early detection of A. pleuropneumoniae in pigs is of vital importance in controlling
this disease. Pigs carrying A. pleuropneumoniae do not necessarily show physical
signs of the disease, and thus can intermingle with healthy pigs in the herd and
transmit the disease. Early detection would allow for segregation of infected pigs
from the herd, protecting other healthy pigs. A s mentioned previously, tests that
are available for early detection of A. pleuropneumoniae

rely mostly on serovar

specific antigens of the pathogen, such as capsular polysaccharides and
lipopolysaccharides. Those tests are good for detecting a particular A.
pleuropneumoniae serovar, but the presence of 12 serovars of this pathogen
makes such tests unreliable. It is therefore important that a n e w detection system
be formulated, one that uses a c o m m o n antigen, thereby facilitating the detection
A. pleuropneumoniae

regardless of serovar.
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Chapter 2: Materials and methods
2.1 Recovery of bacteria from frozen stocks

Escherichia coli and Actinobacillus pleuropneumoniae serovars were recovered
from frozen 2 5 % glycerol stocks by streaking chipped fragments directly onto
chocolate agar plates supplemented with 20 ug/ml N A D (Sigma) (A.
pleuropneumoniae) or Luria Bertani agar plates supplemented with 100 ug/ml
ampicillin (Sigma) (E. coli). All plate cultures were incubated at 37°C, A.
pleuropneumoniae was grown in the presence of 5 % (v/v) C 0 2 .
2.2 Propagation of bacteria in liquid culture

E. coli:

E. coli was grown on Luria Bertani broth supplemented with 100 |ig/ml ampicillin
Single colonies were inoculated into 50 ml starter cultures in a 250 ml Erlenmyer
flasks and grown overnight on a rotatory shaker (Gallenkamp, 160 rpm). Large
scale growth was achieved by adding 10 ml of starter culture into a 300 ml LB
broth supplemented with 100 ug/ml ampicillin and monitoring growth over a period
of time leading to the log phase and subsequently to lag phase.
A. pleuropneumoniae:

A. pleuropneumoniae strains were propagated in brain heart infusion broth (BHIB
(Oxoid) supplemented with N A D (20 jig/ml, Sigma). Single colonies were
inoculated into 50 ml of starter cultures in 250 ml Erlenmyer flasks and grown
overnight on a rotatory shaker (Gallenkamp, 100 rpm). Large-scale growth w a s
achieved by adding 10 ml starter culture into a 300 ml BHIB broth supplemented
with 20 |ig/ml N A D and monitoring growth over a period of time.
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2.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDSPAGE)

Proteins were electrophoretically separated using a mini Hoeffer gel syst
reducing conditions as described by Laemmli (1970). Briefly, 10 m g pelleted whole
cell samples were solubilized in Laemmli reducing mixture (5% w/v pmercaptoethanol; 62.5 m M Tris-CI pH 6.8; 3 % w/v SDS; 1 0 % w/v glycerol).
Bromophenol blue tracking dye (final concentration 2%) was added to the sample.
The samples were boiled at 100°C for 5 minutes. They were then loaded onto a
8 % (E. coli) or 1 0 % and 1 2 % (A. pleuropneumoniae) (w/v) acrylamide running gel
with a 4 % (w/v) stacking gel. Electrophoresis was carried out at constant a 130 V
until the Bromophenol blue tracking dye had electrophoresed to the bottom of the
gel.
2.4 Immunoblot analysis
Proteins were electrophoretically transferred from the acrylamide gel to
nitrocellulose in a BioRad Trans-Blot apparatus (BioRad Laboratories, Richmond,
Ca, USA) under essential conditions described by Towbin et al. (1979) except that
the transfer was carried out at 30 V overnight rather than 60 V for one hour. Briefly,
immunoblots were blocked by incubation in 2 % skim milk-Tris saline-TWEEN (TST W E E N ; 2 % w/v skim milk; 20 m M Tris-CI, pH 7.4; 0.015 M NaCi and 0.01% v/v
Tween 20) for 1 hour and washed with TS-Tween for 5 minutes. The nitrocellulose
containing the proteins was then reacted for 90 minutes with pig sera diluted 1:500
in TS-Tween. The immunoblot was then washed for 15 minutes, with TS-Tween
changed every 5 minutes. Immunoblots were then reacted with horseradish
peroxidase-conjugated goat anti-swine IgG (Kirkegaard & Perry Laboratories,
Gaithersburg, Md.) for 90 minutes. The immunoblots were then washed for 15
minutes with a TS-Tween change every 5 minutes. The immunoblots were then
washed for 5 minutes in freshly prepared 50 m M Tris-HCI buffer (pH 7.6) and the
immunoreactive protein bands developed by adding 50 \i\ freshly prepared
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substrate (50 m M Tris-CI, p H 7.6; 0.12 m M 3,3-diaminobenzidine; 0.03% v/v
H2O2). The reaction w a s stopped by washing immunoblots in milliQ water.
2.5 Enzyme Linked Immunosorbent Assay (ELISA)

Antigens obtained from PAGE-PREP fractionation were diluted to 2 p.g/ml final
concentration in 50 m M bicarbonate buffer (pH 9.6) and 50 ul dispensed into each
well of a 96 well plate (Linbro). The plate was then incubated at 4°C overnight. The
plates were then washed with milliQ water. Individual sera were diluted 1/500 in
TS-Tween 20 and dispensed into the washed plates in a volume of 50 ul. The
plates were incubated at 37°C for 90 minutes. The plates were then washed with
PBS-Tween (phosphate buffered saline containing Tween 20 at 0.05% w/v) and
milli Q water. Goat anti-pig IgG (Kirkegaard & Perry Laboratories, Gaithersburg,
Md.) conjugated to horseradish peroxidase, diluted 1/1000 in TS-Tween, was
added to the wells in a volume of 50 \i\ and incubated for 90 minutes at 37°C. The
plates were again washed with PBS-Tween and milli Q water. After washing, the
binding of the antibodies w a s confirmed by adding 50 p.l 2,2-azino bis (3
ethylbenzthiazoline-6-sulphonic acid) diammonium salt (ABTS) (1 m M A B T S
dissolved in citrate phosphate buffer pH 4.2). The plates were then incubated at
room temperature on a bench-top shaker and the absorbance read at 414 n m
using a Titertek ELISA plate reader.
2.6 Statistics
Student's two-tailed t-Test assuming equal variance was performed (Microsoft
Excel, V97, Microsoft Corporation, Ca) to test the correlation between two sets of
data. The results were taken as being significant if the probability of Student's tTest was less than 0.05.
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Chapter 3: Evaluation of a 39 kDa outer membrane protein (OMP)
of A. pleuropneumoniae as a diagnostic ELISA reagent
3.1 Introduction

Outer membrane proteins of A. pleuropneumoniae are considered important
virulence factors since they are major targets for humoral immune responses in
swine infected with the pathogen (Lu et al., 1988).
The major OMPs of A. pleuropneumoniae are conserved across all 12 serovars.
These include the 16-18 kDa, a 29-32 kDa, a 38-42 kDa and a 48 kDa O M P (Cruz
et al., 1996; Rapp et al., 1986; Thwaites et al., 1991). A 76 kDa O M P has been
reported to be a conserved as well (Thwaites et al., 1991). Outer membrane
proteins of various Gram-negative bacteria have been purified. These include the
O M P s of Pseudomonas

maltophila by the chloroform-methanol method (Chin and

Dai, 1989), membrane proteins of Brucella ovis (Chin and Turner, 1990), as well as
O M P s of Pseudomonas

aeruginosa by sarkosyl lauroyl sarcosinate (SLS) (Chin et

al., 1995). O M P s of A. pleuropneumoniae have also been extracted by several
groups of researchers (Hartmann et al., 1995; Rapp et al., 1986; Thwaites et al.,
1991). The method predominantly used for extraction of membrane proteins as
outlined by Chin and Turner (1990) adopts the following protocols: cell breakage to
release proteins, high speed centrifugation to separate total membrane vesicles
(TMV) containing inner (IMV) and outer membrane vesicles (OMV) from the cell
homogenate, extraction of inner membrane protein (IMP) from inner membrane
vesicle (IMV) using sodium salicylate (SLS) to solubilize the IMV, and high speed
centrifugation on a sucrose pad to separate O M V s from IMPs. The actual process
is described in methods and materials section.
The knowledge that some OMPs are immunodominant and are conserved across
A. pleuropneumoniae serovars (Frey etal., 1996; Jansen, 1994; Maclnnes and
Rosendal, 1987) leads to the possibility of using those O M P s as ELISA antigens in
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the detection of A. pleuropneumoniae. The current ELISA antigens are serovar
specific as they usually rely on capsular polysaccharides or lipopolysaccharides
(Gottschalk et al., 1994; Bosse et al., 1990; Radacovici et al., 1994).
Lipopolysaccharides are unique for each serotype, due to differences in the side O
chain in terms of its length, composition and structure. The use of L P S in ELISA
assays is therefore limited to a particular serotype. Serovar specificity is not helpful
when any one of the 12 serotypes can be present during the course of an infection.
The use of ELISA for detecting A. pleuropneumoniae regardless of the serotype
would be enhanced greatly if a c o m m o n A. pleuropneumoniae antigen were used
as an ELISA antigen. Possible use of O M P s of A. pleuropneumoniae as c o m m o n
ELISA antigens for the detection of swine pleuropneumoniae was therefore an
important topic of research.
3.2 Materials and methods
Only specific materials and methods pertaining to this chapter other than general
materials and methods are outlined in this section.
3.2.1 Extraction of outer membrane proteins (OMPs)
Methods outlined by Chin and Turner (1990) were adopted for the purposes of
O M P extractions. Bacteria were propagated in broth culture as outlined in the
Materials and Method section (Chapter 2). Bacterial cells were killed by addition of
0.5% v/v phenol to the growth culture and incubation at 4°C for 1 hour, after which
the killed cells were French pressed (4 passes, 8000 psi) (Chin and Scully, 1986)
and centrifuged (15,000g, 10 min, 4°C). The pellet was discarded and the
supernatant centrifuged again (15,000g, 15 min, 4°C). The resulting supernatant
was then layered onto a sucrose pad ( 2 0 % sucrose/50 m M H E P E S ) and
centrifuged (150,000g, 90 min, 4°C) (Chin and Dai, 1990). The pellet (TMV or total
membrane vesicles) containing both inner and outer membrane vesicles (IMV and
O M V ) was then rinsed with 50 m M H E P E S and resuspended in 2 % SLS/50 m M
H E P E S and rotated overnight (33 rpm) at room temperature (Filip et al., 1973).
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This step selectively extracted the inner membrane proteins from the inner
membrane vesicle leaving behind the outer membrane vesicles intact. The
preparation was then loaded onto a sucrose gradient consisting of discrete layers
of 60,40 and 2 0 % (w/v) sucrose. Following centrifugation at 150,000g for 90 min at
4°C, the outer membrane vesicles were located at the 60/40% (w/v) interphase
while inner membrane proteins remained above the 2 0 % (w/v) sucrose layer.
3.2.2 Preparative SDS-PAGE
Preparative SDS-PAGE (PAGE-PREP) technology was used to purify soluble
antigen of known molecular weight from whole cell preparations. The BIO-RAD
Prep Cell (Model 491) apparatus assembly, gel preparation, and use were
performed as per manufacturer's instructions.
A. pleuropneumoniae cells (100 mg) were reduced in 1 ml Laemmli reducing
mixture [(5% p-Mercaptoethanol (w/v); 62.5 m M Tris-CI pH 6.8; 3 % S D S ; 1 0 %
glycerol (w/v)] by boiling (Laemmli, 1970), and several crystals of bromophenol
blue were added to dye the sample. The cell preparation w a s loaded onto a 9 %
polyacrylamide gel column (Bioprep 491 cell, Bio-Rad), 9 c m in height with a 1 cm
stacking gel consisting of 4 % polyacrylamide. Columns were run at 40 m A constant
current (150-300 V) for 11 hours and fractions (9 ml) were collected immediately
after elution of the bromophenol dye. The electrophoresis and elution buffers
comprised S D S - P A G E buffer (0.1% S D S , 50 m M Tris, 384 m M glycine), and the
flow rate was 1 ml min"1.
Fractions obtained from PAGE-PREP were analyzed by running minigel SDSP A G E (8 x10 cm, 1.5 m M thickness) consisting of a 1 0 % separating gel and 4 %
stacking gel. 4 X Laemmli reducing mix was added to part of every second sample
to give afinaldilution of 1X. The fractions were boiled, and 30 jil samples were
then loaded onto the minigel and run (130 V constant voltage) until the
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bromophenol dye reached the bottom of the gel. The gels were then stained with
Rapid silver staining method (Bloom et al., 1987).
3.2.3 Production of pig antisera

Reference antisera against type strains of Actinobacillus pleuropneumoniae
representing serovars 1, 7 and 12 were generated by vaccinating pigs (n=3) with
3x10 6 C F U bacteria formulated in Emulsigen (Intervet/Ausvac/Australia). Pigs were
vaccinated on three occasions 4 weeks apart and blood w a s collected 4 weeks
after the last immunization.
To simulate infection regimes, three groups of 3 pigs were each challenged
intranasally (IN) with 5x10 9 C F U (in a volume of 1 ml saline) bacteria representing
one of the three Actinobacillus pleuropneumoniae type strains. The IN challenged
pigs were then allowed to mingle with uninfected cohort pigs (n=6) per group and
blood was collected at weekly intervals for 6 weeks from these animals. Pigs used
in each of the three experimental groups were confined to separate rooms to
ensure that there w a s no cross-lateral transmission of representative Actinobacillus
pleuropneumoniae serovars.
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3.3 Results

3.3.1 S D S - P A G E analysis of three of the most commonly isolated serovars of
A. pleuropneumoniae

in Australia

Most of the commonly isolated strains of A. pleuropneumoniae in Australia belo
to serovars 1, 7 and 12 (Blackall and Pahoff 1995). Type strains 4074, W F 8 3 and
1096, selected to represent serovars 1, 7 and 12 respectively, were analyzed by
S D S - P A G E under denaturing conditions in an effort to compare the polypeptide
antigenic profile. Fig 3.1 shows the presence of at least six intensely stained bands
corresponding to molecular sizes of 28 kDa, 30 kDa, 39 kDa, 48 kDa, 67 kDa and
85 kDa in all three serovars. The other minor bands that were present in the three
serovars included those resembling a 33 kDa, a 35 kDa, a 37 kDa, a 42 kDa, a 55
kDa, a 60 kDa, a 70 kDa as well as a 93 kDa band.
3.3.2 Immunoreactivity of polypeptide antigens of 3 type strains
representing serovars 1 (HS54), 7 (WF83) and 12 (HS143)
The immunoreactivity of polypeptide antigens of serovars 1, 7 and 12 were
analyzed by immunoblotting. Whole cell bacteria from each type strain was
denatured, electrophoresced by S D S - P A G E and transferred to nitrocellulose
membrane. Fig 3.2 shows the immunoreactivity of the 3 type strains following
reaction with pooled serum from pigs that had been hyper-vaccinated against
HS54 (Sv1, panel A) or W F 8 3 (Sv 7, panel B) or HS143 (Sv 12, panel C). The
most prominent immunoreactive bands had apparent molecular sizes of 22 kDa, 30
kDa, 39 kDa and 67 kDa. These bands were consistently found to be
immunoreactive for all 3 type strains against sera generated against each of the 3
type strains.
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Figure 3.1 Polypeptide fingerprint analysis of A. pleuropneumoniae type strains on a S D S - P A G E
gel. Whole cell bacteria, after resuspension in 1x Laemmli reducing mix and boiling, were run on a
1 2 % SDS-polyacrylamide gel and stained with Coomassie blue. Lane A, A. pleuropneumoniae type
strain 1 (HS54); Lane B, A. pleuropneumoniae type strain 7 (WF83); Lane C, A. pleuropneumoniae
type strain 12 (HS143); Lane D, molecular weight standards (in kDa). Arrowhead indicates the
position of the 39 kDa outer membrane protein (OMP). Bold fonts (left of figure) indicate the major
bands.
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Figure 3.2 Immunoblots (A, B and C) depicting the immunoreactive protein bands of A.
pleuropneumoniae serovar 12 (type strain HS143), lane 1; serovar 7 (type strain WF83), lane 2;
and serovar 1 (type strain HS54), lane 3. Blot A was reacted against sera from pigs vaccinated with
A. pleuropneumoniae serovar 1 (HS54). Blot B was reacted against sera from pigs vaccinated with
A. pleuropneumoniae serovar 7(WF83). Blot C was reacted against sera from pigs vaccinated with
A. pleuropneumoniae serovar 12 (HS143). The immunoreactive common bands are labeled on the
right. Control antibody was not tested. Sera were kindly provided by Dr. Chin, Dr. Eamens and Dr.
Giles at EMAI).
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3.3.3 Extraction of O M P s from type strains representing serovars 1, 7 and 12

To identify whether the four immunoreactive antigens (22, 30, 39 and 67 kDa in
Fig. 3.2) associated with each serovar were O M P s , total membrane vesicles (TMV)
were prepared from bacteria representing each of the 3 type strains. The T M V
were then subjected to SLS treatment to solubilize inner membrane proteins while
outer membrane vesicles were recovered intact by ultracentrifugation. Fig 3.3
shows the presence of a 22, 30, 39 and 67 kDa O M P s for Sv1. The profiles of
O M P s were similar also for Sv7 and 12 (Gardiner, 1996).
3.3.4 Immunoreactivity of common OMPs of A. pleuropneumoniae serovars
1,7 and 12
The immunoreactivity of OMPs extracted from A. pleuropneumoniae serovars 1
(HS54), serovar 7 (WF83), and serovar 12 (HS143) were analyzed by
immunoblotting. O M P fractions obtained from each serovars was denatured,
electrophoresed by S D S - P A G E and transferred to nitrocellulose membrane. Fig
3.4 shows the immunoreactivity of the O M P s of the 3 type strains following reaction
with pooled serum from pigs that had been hyper-vaccinated against H S 5 4 (Sv1,
panel A) or W F 8 3 (Sv 7, panel B) or HS143 (Sv 12, panel C). The most prominent
immunoreactive bands had apparent molecular sizes of 30 kDa, 32 kDa, 39 kDa,
48 kDa and 67 kDa. These bands were consistently found to be immunoreactive
for all 3 type strain O M P s against sera generated against each of the 3 type
strains.
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Figure 3.3 S D S - P A G E profiles of A. pleuropneumoniae bacteria and membrane fractions in 1 2 %
acrylamide stained with Coomassie blue. Lane 1, molecular standard markers (in kDa); Lane 2,
HS54 whole cell; Lane 3, outer-membrane vesicles resolved by sucrose density centrifugation and
Lane 4, inner-membrane proteins extracted by sarkosyl extraction. Arrowheads indicate the position
of four major O M P s .
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Figure 3.4 Immunoblot depicting the immunoreactivity of O M P s extracted from serovars 1 (type
strain HS54), 7 (type strain W F 8 3 ) and 12 (type strain HS143) (depicted in lanes 1, 2 and 3
respectively) against sera from pigs vaccinated with different A. pleuropneumoniae serovars. 10 ng
O M P preparation w a s loaded onto a 1 2 % S D S - P A G E gel and after transfer onto nitrocellulose,
reacted against sera from pigs that have been vaccinated with A. pleuropneumoniae serovar 1, 7 or
12. Blot A w a s reacted against sera from animals vaccinated with A. pleuropneumoniae serovar 1
(HS54). Blot B w a s reacted against sera from animals vaccinated with A. pleuropneumoniae
serovar 7 (WF83). Blot C w a s reacted against sera from animals vaccinated with A.
pleuropneumoniae serovar 12 (HS143). The apparent molecular sizes of the c o m m o n
immunoreactive O M P s are presented on the right.
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3.3.5 Purification of the 39 kDa O M P subunit antigen by Preparative S D S PAGE
Preparative S D S - P A G E method w a s used to resolve various antigens of A.
pleuropneumoniae whole cell, including the 39 kDa O M P . Cell pellet corresponding
to 100 m g in wet weight w a s denatured by resuspension in Laemmli's reducing mix
and boiling, after which the suspension was run on a preparative S D S - P A G E
column. A total of 50 fractions were collected, and every fourth fraction was
analyzed by a 1 0 % acrylamide (v/v) S D S - P A G E gel stained using silver nitrate
method. Fig. 3.5 shows the presence of various sized subunit antigens of A.
pleuropneumoniae ranging from less than 14 kDa to 40 kDa in size. Included in
those fractions were bands that resembled 33-40 kDa proteins, as analyzed
against molecular weight standards. Fractions that contained those antigens were
further analyzed in immunoblot assays to identify the immunodominant antigens.
Fractions containing subunit antigens resolved by preparative SDS-PAGE that
were observed to have molecular weights between 33 kDa and 40 kDa were
selected, and re-run on a S D S - P A G E gel. These were then transferred onto
nitrocellulose and immunoblotted. After blocking, immunoreactive subunit antigens
were visualized byfirstreacting the blots with A. pleuropneumoniae serovar 1
vaccinated pig sera, followed by horseradish-peroxidase conjugated goat antiswine IgG and diaminobenzidine as H R P substrate. After the addition of substrate,
a band corresponding to 39 kDa O M P w a s observed in fractions 46-50 (fig. 3.6).
No other immunoreactive bands were visible. Fractions corresponding to the 39
kDa O M P (46-50) were pooled together and stored at -20°C. To further confirm the
location of the 39 kDa O M P in the fractions obtained, fractions were profiled using
ELISA to identify immunoreactive fractions that appeared to carry the 39 kDa O M P .
Earlier results obtained from immunoblots had shown immunoreactive bands
corresponding to 39 kDa O M P to be present in fractions 46 to 50 (fig. 3.6).
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Figure 3.5 Silver stained S D S - P A G E gel depicting subunit antigens of whole cell A.
pleuropneumoniae fractionated by preparative S D S - P A G E . Fractions collected after the preparative
S D S - P A G E run were analyzed on a 1 0 % S D S - P A G E gel by first adding 4x Laemmli reducing mix,
boiling the sample, and then loading 30 ^l of every fourth fraction. The protein bands were
visualized by silver staining method. Arrows indicate the position of the 39 kDa O M P . Fraction
numbers are presented above each lane. Lane 1 contains molecular weight standards. Fractions
containing the 39 kDa antigen are observed in fractions 46 and 50. "M" represents Standard
Markers; "O" represents outer membrane proteins of A. pleuropneumoniae.
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Fraction

O

34 36 38 42 44 46 48 50 52 54 56 58 60

20kDa'

Figure 3.6 Immunoblot depicting the 39 kDa O M P s of A. pleuropneumoniae fractionated by
preparative S D S - P A G E . Every second fraction w a s selected and re-run on a 1 0 % acrylamide S D S P A G E gel. The proteins were then transferred onto nitrocellulose and reacted with sera from pigs
vaccinated with A. pleuropneumoniae serovar 1 (HS54). Lane numbers represent the
corresponding fraction numbers respectively. "O" represents purified O M P sample. The arrowheads
represent the corresponding 39 kDa immunodominant O M P s . The presence of the 39 kDa protein
is observed in fractions 46-50 as indicated by single bands in those lanes. A separate control
antibody w a s not required for the purposes of this experiment.
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Proteins in fractions observed to contain the 39 kDa O M P were coated onto ELISA
plates. These were then reacted with sera from pigs hypervaccinated with A.
pleuropneumoniae serovar 1. Results showed strong reactivity (indicated by ELISA
O D >0.5 as compared to low ELISA O D s of other reactive fractions) in fractions 4650 corresponding to the location of the immunodominant 39 kDa O M P (fig. 3.7).
3.3.6 Assessment of the 39 kDa OMP of A. pleuropneumoniae as an ELISA
antigen

The purified 39 kDa OMP was assessed as an ELISA reagent by reacting it against
sera from pigs that were experimentally challenged with A. pleuropneumoniae (fig.
3.8). Animals were either challenged with A. pleuropneumoniae serovar 1, 7 or 12.
Sera were collected at day 0 (pre challenge) and weekly thereafter. Each pen
consisted of challenge animals as well as control contact animals that had not
been challenged with the pathogens but were in constant contact with the infected
pigs. Fig. 3.8A shows the ELISA reactivity of sera from serovar 1 (HS54)
challenged and contact pigs against the 39 kDa antigen. In this case, none of the
contact showed a serological response while the challenged pigs displayed a
strong ELISA reaction against the 39 kDa O M P .
The immunoreactivity against the 39 kDa OMP antigen by sera from animals
challenged with serovar 7 (Fig. 3.8B) and contact animals housed in the same pen
yielded a different result. While immunoreactivity against the 39 kDa O M P antigen
was strong in both groups of animals, there w a s no significant difference in their
immunoreactivity against the antigen. The immunoreactivity increased from day 0
to day 4 of challenge (and contact) and once it peaked at day 14, it leveled off for
the rest of the trial period (until day 42).
Fig 3.8C shows the immunoreactivity of the 39 kDa OMP antigen against sera from
animals challenged with serovar 12 (HS143) and contact animals housed in the
same pen with the challenged animals. The ELISA results showed that the 39 kDa
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antigen w a s immunoreactive against both groups. There was no significant
difference in the immunoreactivity between the challenge group and contact group
Immunoreactivity increased from day 0 to day 14 after challenge and remained
constant until day 42 after challenge.

The immunoreactivity of the purified 39 kDa OMP was further assessed by reacting
the antigen against sera from 12 randomly selected healthy piglets that had been
brought into a commercial piggery with endemic pleuropneumonia. Serum was
collected at days 28, 60, 92 and 128 after introduction into the piggery. The
immunoreactivity shown by the 39 kDa O M P antigen was then compared against
the immunoreactivity shown against A. pleuropneumoniae serovar 1 whole cell
used as an ELISA antigen by the s a m e sera.
Fig. 3.9A depicts the immunoreactivity of the 39 kDa OMP antigen against sera
from infected pigs at days 28, 60, 92, and 128 as measured by ELISA. An increase
in immunoreactivity, as indicated by higher ELISA reactivity, was observed with
increasing time and maximum ELISA reactivity w a s observed for most pigs at days
92 and 128. Fig. 3.9B depicts the immunoreactivity of the A. pleuropneumoniae
whole cell antigen against sera from infected pigs at days 28, 60, 92 and 128 as
measured by ELISA. This was carried out in order to validate the efficiency of the
39 kDa subunit antigen as a possible diagnostic reagent. The 39 kDa antigen was
observed to be immunoreactive during the course of the infection. Results showed
that while the immunoreactivity of the 39 kDa O M P antigen w a s low compared to
the whole cell antigen during days 28 and day 60, the immunoreactivity shown by
the 39 kDa O M P w a s comparable to A. pleuropneumoniae whole cell when used
as an ELISA antigen at days 92 and 128 (fig. 3.9B).

35

D P re • P ost

Figure 3.7 ELISA profiling of A. pleuropneumoniae serovar 1 (HS54). Fractions obtained from
preparative S D S - P A G E were taken and diluted to 2ug/ml. After coupling onto ELISA plates,
samples were first reacted against sera from pigs challenged with A pleuropneumoniae serovar 1
(HS54), and then against goat anti-swine IgG labeled with horseradish peroxidase. Serum from
pigs prior to A. pleuropneumoniae challenge w a s taken as negative control and is indicated by the
white bars and labeled as "pre". Dark bars depict post challenge pig sera, labeled as "post". Error
bars represent standard deviation of each set of data from the m e a n value for the set
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Fig 3.8 Assessment of 39 kDa O M P as an ELISA antigen. Healthy pigs were either challenged with
A. pleuropneumoniae serovars 1 (HS54), 7 (WF83) and 12 (HS143) or used as contact controls in
the same pen. (A) Represents immunoreactivity against 39 kDa O M P by pig sera from animals
challenged with A. pleuropneumoniae serovar 1 at different time points, day 0 being pre-challenge
sera, as assessed by ELISA. (B) Represents immunoreactivity against 39 kDa O M P by pig sera
from animals challenged with A. pleuropneumoniae serovar 7. Similarly, (C) represents
immunoreactivity against 39 kDa O M P by pig sera from animals challenged with A.
pleuropneumoniae serovar 12. Error bars represent standard deviation of each set of data from the
mean value for the set. [I would like to acknowledge the contributions of Dr.Graeme Eamens (in
providing the sera), Dr.James Chin (providing sera), and Bernadette Turner (hands on assistance),
in this ELISA assessment experiment].
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Figure 3.9 Assessment of 39 kDa O M P as an ELISA antigen. Pig sera were obtained from a
commercial piggery with endemic pleuropneumonia and reacted with an antigen panel consisting of
(A) purified 39 kDa O M P antigen and (B) A. pleuropneumoniae whole cells. The pig sera were
obtained from pigs that had initially been introduced into the piggery as healthy pigs and had been
housed there for 28 days, 60 days, 92 days, and 125 days respectively. Immunoreactivity was
detected by standard ELISA using H R P conjugated goat anti-swine IgG. The immunoreactivity
against A. pleuropneumoniae whole cell was monitored as a positive control. (I would liketothank
Dr. James Chin for providing the sera, and to Bemadette Turner for assisting in s o m e of the ELISA
procedures).
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3.4 Discussion

Host immune responses are directed mainly against surface antigens of invading
pathogenic bacteria during the primary encounter between host and pathogen
(Costerton et al., 1981). In Gram-negative bacteria, front-line antigens recognized
by the host immune system are usually those arrayed in the outer membrane,
commonly referred to as O M P s (Chin & Dai, 1989). Since their very presence on
the surface of Gram-negative bacteria renders them prime targets for the immune
system, it was hypothesized that these O M P s may be useful serological reagents
for the detection of antibody responses against App in infected pigs. The utility of
these antigens would be determined by the following requirements:
1. that they were common antigenic determinants to different App serovars
2. that one or more O M P s are immunogenic and immunodominant
3. that antibodies produced against these antigens are associated with a
productive infection
The studies reported here were directed towards an examination of the antigenic
composition of three type strains of A. pleuropneumoniae representing serovars 1,
7 and 12. These were chosen because the three serovars constitute by far, the
most frequently isolated serovars from pigs with pleuropneumonia in Australia
(Blackall and Eaves, 1986).
Analysis of polypeptide bands by Coomassie Blue showed strong staining bands
corresponding to 28 kDa, 30 kDa, 39 kDa, 48 kDa, 67 kDa and 85 kDa in all three
serovars. Other reports have shown that the 42 kDa, 39 kDa, 29 kDa and 16 kDa
bands were darkly stained in A p p serovars 1 to 9 (Rapp et al., 1986). Of these, the
28kDa, the 39 kDa, and the 48 kDa were confirmed to be O M P s when purified by
the Sarkosyl protocol (Rapp etal., 1986; Thwaites etal., 1991).
Having confirmed the presence of c o m m o n dominant antigens in all three serovars, it
was important to demonstrate that s o m e of these antigens were indeed outer
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membrane proteins. This w a s accomplished using the procedure of Chin and Turner
(1990). The method used for the extraction involved solubilization of the inner
membrane vesicles in a T M V complex m a d e up of O M V s and IMVs. This allowed the
extraction of the O M V s from the IMV complex. Further high-speed centrifugation
separated the O M V s from IMPs. The extraction yielded a number of O M P bands on
S D S - P A G E gel, including a prominent darkly stained 39 kDa O M P band (fig. 3.3). Other
bands included an 85 kDa, 75 kDa, a 48 kDa, a 42 kDa, a 32 kDa and a 28 kDa band.
The presence of the 39 kDa bands in the outer membrane fractions of all three serovars
confirmed the finding by Rapp and colleagues (1986) that the 39 kDa O M P of A.
pleuropneumoniae is conserved across all serovars.

When the OMP preparations were reacted against sera from pigs challenged with eac
of the three serovars, several bands showed immunoreactivity, including the 39 kDa
O M P band, regardless of the serovar from which the O M P s were extracted. This was
consistent with the results of Rapp and colleagues (1986) showing the
immunodominance of the 39 kDa O M P . This finding is also consistent with previous
studies where it w a s observed that O M P preparations from three A. pleuropneumoniae
serovars (1, 5 and 7), when reacted with sera from pigs challenged with serotype 5,
showed the presence of a prominent band resembling the 39 kDa O M P (Rapp & Ross,
1986).

The presence of the 39 kDa antigen across the serovars and its strong immunoreact
nature m a d e it an ideal ELISA candidate. The 39 kDa O M P from the three serovars w a s
purified using a method known as preparative S D S - P A G E . The use of preparative S D S P A G E is recent. Chin & Djordjevic (BIO-RAD bulletin 2036) have been able to identify
and purify subunit antigens of Mycoplasma hyopneumoniae and Erysipelothrix
rhusiopathiae using this procedure. Scarman et al. (1997) have shown the efficacy of
using this procedure in the comparison of protein and antigenic profiles of three porcine
pathogens, Mycoplasma hyopneumoniae, Mycoplasma hyorhinis and Mycoplasma
flocculare. This group developed and evaluated a preparative S D S - P A G E profiling
technique that combined the advantages of the electrophoretic separation of proteins
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with the convenience and speed of ELISA to quantify immunoreactivity of certain
antigens.

Using this method, A. pleuropneumoniae cell pellet was fractionated into various
molecular sizes and the fraction containing the 39 kDa soluble O M P antigen identified
based on the molecular size of the protein on a S D S - P A G E gel. The identity of the 39
kDa band w a s further confirmed by immunoblotting where the different fractions were
reacted against sera from pigs vaccinated with A. pleuropneumoniae serovar 1(HS54).
The 39 kDa band w a s visible in the immunoblot and w a s located in fractions 46-50.
The 39 kDa OMP antigen was reacted against sera from pigs that had been challenged
with three different A. pleuropneumoniae serovars (serovars 1, 7 and 12). The aim w a s
to observe and assess the immunoreactivity of the sera against the 39 kDa antigen.
Animals challenged with serovar 1, 7 and 12 showed strong immunoreactivity against
the 39 kDa O M P antigen within a short period after challenge. The immunoreactivity
against the 39 kDa O M P was significantly better (P<0.05, two tailed T-test) by sera from
animals challenged with A. pleuropneumoniae serovar 1 (HS54) than by sera from
contact animals after the first week of challenge, continuing until 6 weeks after
challenge. In this case, the immunoreactivity against the 39 kDa O M P antigen w a s
lower ( O D < 0.5) for contact animals at all time points.

The immunoreactivity, as quantified by ELISA, was not significantly different (P>0.1
tailed T-test) between challenge and contact group for animals challenged with A.
pleuropneumoniae serovar 7 and 12 respectively. O n e possible reason for this could be
that the animals challenged with serovar 7 and 12 were transferred back to their herd
housing unchallenged pigs immediately after challenge, while they were still
unconscious. Animals challenged with serovar 1 were isolated for 24 hours after
challenge before returning them to their herd housing unchallenged pigs. During this
time, the innate immune response would have neutralized residual pathogen, lowering
the number of pathogen transmitted to "healthy" animals. This was not true for those
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pigs challenged with serovars 7 and 12, since they were more likely to transmit the
higher number of residual pathogen directly to the "healthy" pigs in the herd.

The ELISA assay involving the 39 kDa OMP was further used to assess the antibody
reactivity of sera from feeder pigs whose growth was being monitored over time
following introduction into a piggery with endemic pleuropneumonia. Results showed
that the 39 kDa O M P is recognized by antibodies present in the pig sera from day 28.
This is an important result because it shows that the 39 kDa O M P can be used to detect
the presence of antibodies against A. pleuropneumoniae early in the course of an
infection. Furthermore, the immunoreactivity of the 39 kDa O M P antigen w a s
comparable to that of A. pleuropneumoniae whole cell used as a control positive antigen
in the experiments.
The results obtained using the 39 kDa OMP antigen as a possible diagnostic reagent
have been promising. It has been shown from this research project that the 39 kDa
antigen can detect the presence of A. pleuropneumoniae in challenged as well as
infected pigs. Although m e m b r a n e proteins from other gram-negative bacteria have
been used as ELISA antigens (Chin and Turner, 1990; Chin and Dai, 1989), s a m e is not
true regarding membrane proteins of A. pleuropneumoniae. The use of the A.
pleuropneumoniae 39 kDa O M P as an ELISA reagent has not been reported to date.
To our knowledge, this is thefirsttime the 39 kDa O M P of A. pleuropneumoniae has
been trialed in such an assay. The results obtained from this work have only shown that
the 39 kDa antigen is useful in detecting A. pleuropneumoniae during the course of an
infection. The questions of sensitivity as well as species-specificity have to be
addressed in future trials involving this antigen. The issues of cross reactivity as well as
non-reactivity of sera from pigs infected with other members of H A P family of bacteria
against the 39 kDa O M P antigen have to be investigated as well. It can be stated
without doubt that further trials are necessary to fully establish the significance of using
the 39 kDa O M P as an ELISA antigen.
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Chapter 4: Characterization, purification and serological
evaluation of a recombinant toxin- ApxIV
4.1 Introduction

A. pleuropneumoniae strains are known to produce at least one or a combination
of three extracellular toxins -Apxl, Apxll and Apxlll (Frey, 1994; Frey etal., 1993;
Frey et al., 1994). The combination of secreted toxin or hemolysin is characteristic
for a given serotype (Beck et al., 1994) and it has been proposed that the virulence
of each strain is highly dependent upon the combination of exotoxins secreted
(Freyefa/., 1993).
Apxl is secreted by serotypes 1, 5a, 5b, 9,10 and 11 (Beck et al., 1994) while
Apxll is produced by all serotypes except serotype 10 (Kamp et al., 1991). Apxlll is
secreted by serotypes 2, 3, 4, 6 and 8 (Kamp et al., 1991). Apxl and Apxll are
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hemolytic. Apxlll is cytotoxic to pig neutrophils. All three exotoxins belong to the
family of R T X toxins, which includes the hemolysin toxin of E. coli, leukotoxins of
Pasteurella and Actinobacillus, and the adenylate cyclase-hemolysin of Bordetella
pertussis. The R T X toxins contain a hydrophobic domain in the N-terminal, a
calcium-binding domain in the C- terminal and a lysine rich region involved in the
acylation of the inactive pro-hemolysin (Fig. 1.1)(Stanley etal., 1998).
Thompson et al (1994) reported that Neisseria meningitidis also produces two ironregulated proteins (FrpA and FrpC) related to the R T X family of exoproteins. While
investigating the expression and phylogenetic relationships of a novel lacZ gene in A.
pleuropneumoniae, Anderson and McGuinnes (1997) were able to identify sequences
similar to the frpA and frpC genes of Neisseria meningitidis downstream of the lacZ
gene in A. pleuropneumoniae. The possibility that this homology might encode a new
Apx protein w a s further explored by Schaller et al., (1999) w h o were successful in
cloning and expressing the n e w Apx gene - apxIV in E.coli.
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According to Schaller et al. (1999), the apxlV gene w a s detectable by D N A
hybridization in all A. pleuropneumoniae strains. However, various strains m a y
produce different polymorphic forms of the toxin. For example, sequence data of
the apxIV gene from the 2 type strains Shope 4074 (serovar 1) and H V 1 1 4
(serotype 3) show that apxIV gene encodes toxins with molecular sizes of 202 and
170 kDa respectively.

The role of ApxIV in pathogenesis has not been elucidated. Yet, the toxin appears
to have an extremely interesting property. Unlike other Apx toxins, ApxIV is never
produced during in vitro culture by virulent strains of A. pleuroponeumoniae. Its
production in the course of in vivo infection is only documented indirectly from
immunochemical data where sera from infected pigs, were found to react in
immunoblots against the ApxIV antigen expressed by E. coli. Thisfindingclearly
needs further corroboration and would be of immense value as a diagnostic
antigen for the detection of infection by A. pleuropneumoniae if antibody responses
against ApxIV could be quantified in an ELISA test.
There are very few published studies where Apx toxins have been used in an
indirect ELISA test. To develop such an ELISA, Devenish etal., (1990) had to
firstly purify Apx from A p serovar 1 strain CM-5. The purified toxin (104 kDa,
supposedly Apxll) w a s then used as an immunogen to generate rabbit polyclonal
antibodies from which the toxin-specific IgG w a s affinity purified. The purified rabbit
anti-Apx w a s then used as the coating antibody in ELISA plates to capture Apx
protein from crude bacterial supernatants. M a and Inzana (1990) also used a
similar approach to generate a 110 kDa toxin (supposedly Apxl) from A p serovar 5
strain J45. However, since serovars 1 and 5 are known to secrete both Apxl and II,
it is not clear from these reports which of the two antigens were being captured and
used in the ELISA test. The quality control procedures to confirm the identity of
either Apxl or Apxll were simply not carried out. It is evident that ELISA assay
reagents produced by complex procedures require extensive quality control steps
to be implemented before the antigen can be utilized as a diagnostic reagent. The
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establishment of a toxin-based ELISA would be very much simplified if an easier
and less time consuming procedure were to be developed for the production of Apx
toxin antigen.

Another factor that may interfere with the use of a toxin based ELISA assay is the
possibility of cross-reactivity with toxins produced by species other than A.
pleuropneumoniae. For instance, sera from pigs infected with A. suis (known to
produce a toxin identical to Apxll of A. pleuropneumoniae, Burrows and Lo,1992)
reacted with Apxl/ll toxin from serotype 1 and failed to against Apxl/ll prepared
from serotype 5 (Kamp et al., 1994). Such observations render the ELISA test less
specific in its diagnostic capability. Unlike Apx I, II and III, the observation that the
apxlV gene is present in all A. pleuropneumoniae serovars endorses the possibility
that the ApxIV antigen is c o m m o n to all strains. Consequently, the use of purified
recombinant ApxIV (rApxIV) as an ELISA reagent will provide an additional
supporting test to the 39 kDa O M P antigen.
The aims of this chapter are as follows:
1. To induce the production of rApxIV from plasmids constructed to express either
the C-terminal or N-terminal of ApxIV (i.e. C-ApxIV and N-ApxIV).
2. To purify C-ApxIV and N-ApxIV by Preparative S D S - P A G E .
3. To evaluate purified C-ApxIV and N-ApxIV antigens as ELISA reagents for the
detection of antibodies against A. pleuropneumoniae in infected pigs.

4.2 Materials and Methods
This section follows methods and materials already outlined in chapter 2. Materials
and methods outlined here pertain only to experiments carried out in this chapter.
4.2.1 Bacterial strains and plasmids used
Table 4.1. List of bacteria used
Bacterial strain

Genotype

Source/Reference

HMS147(DE3)

E. coli

Dr. J. Frey (University of
Berne, Switzerland)

JM109^pir*

E.coli

(Yanisch-Peron ef al.,
1985)

*E.coli JM109X.pir w a s used as a control E.coli host carrying the His-tag plasmid pQE9.

Table 4.2. List of plasmids used
Plasmid

Phenotype

Source/Reference

pJFFapxlVA1NaHis1

ApVN-apxIV

Dr. J. Frey (University of
Berne, Switzerland)

pJFFapxlVA3CHis1

ApVC-apxIV

Dr. J. Frey (University of
Berne, Switzerland)

pQE9**

Ap7His-tag®

Novagen

** Plasmid p Q E 9 w a s used as a His-tag control plasmid since the original expression plasmid used by
Schaller and colleagues, pET14b w a s not available. The use of p Q E 9 w a s based on the similarity
between the two plasmids in that both were capable of expressing His-tagged protein under IPTG
induction, and both confer ampicillin resistance.

4.2.2 Induction of expression of recombinant protein antigens
E. coli colonies expressing the recombinant toxins (Schaller et al., 1999) were
inoculated intolO ml overnight LB broth supplemented with 100 u.g/ml ampicillin. A
5 ml aliquot of the overnight culture w a s used to inoculate 50 ml starter cultures in
250 ml Erlenmyer flasks. Growth of bacteria was monitored until start of log phase
(absorbance O D of 0.5 at 650nm). At this point, the bacteria were induced with 0.5
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m M or 2.0 m M isopropyl-p-D-thiogalactopyranoside (IPTG) and grown for a further
3 hours. Bacteria were then centrifuged (5000 g, 30 min, 4°C) in a Beckman highspeed centrifuge. The pellets were weighed, aliquoted and stored at -20°C.

4.2.3 Preparative SDS-PAGE fractionation

Preparative SDS-PAGE (PAGE-PREP) technology was used to purify soluble
antigen of known molecular weight from whole cell preparations. The Prep Cell
was obtained from BIO-RAD (Model 491). Apparatus assembly, gel preparation,
and use were all performed as per manufacturer's instructions.
E.coli HMS147(DE3) cells carrying the recombinant clones were reduced in
Laemmli mixture [(5% p-Mercaptoethanol (w/v); 62.5 m M Tris-CI pH 6.8; 3 % SDS;
1 0 % glycerol (w/v)] by boiling (Laemmli, 1970), and several crystals of
bromophenol blue were added to the sample. Cell preparation was loaded onto a
9 % polyacrylamide gel column (Bioprep 491 cell, Bio-Rad), 9 c m in height with a 1
cm stacking gel consisting of 4 % polyacrylamide. Columns were run at 40 m A
constant current (150-300 V) for 11 hours and fractions (9 ml) were collected
immediately after elution of the bromophenol dye. The electrophoresis and elution
buffers comprised S D S - P A G E buffer (0.1% S D S , 50 m M Tris, 384 m M glycine),
and the flow rate used was 1 ml min"1.
Fractions obtained by PAGE-PREP were analyzed by running minigel SDS-PAGE
containing a 8 % separating gel and 4 % stacking gel.
4.2.4 Scan profile analysis of protein bands
Bio-rad Molecular Analyst software was used in quantitative analysis of protein
bands in S D S - P A G E gels. Gels were scanned using a Bio-rad densitometer, and
subsequently analyzed using Molecular Analyst software for quantifying the
percentage of protein in the given lane.
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4.3 Results

4.3.1 Effect of IPTG on growth of host E. coli

Growth of the bacteria was monitored at various time points either in the presence
of 2 m M IPTG or in the absence of IPTG (fig. 4.1). Results showed reduced growth
rate of the host E. coli expressing recombinant N-apxIV in the presence of IPTG
(fig.4.1C). Growth w a s also reduced in the presence of IPTG in the growth culture
of E. coli expressing recombinant C-apxIV (fig. 4.1 B). Growth of E. coli J M 1 0 9 X.pir
carrying plasmid p Q E 9 was also monitored as a negative plasmid control
(fig.4.1A). Growth w a s not repressed significantly in the presence of IPTG during
growth of this bacterium.
4.3.2 Polypeptide fingerprint analysis of E. coli strains in the presence and
absence of IPTG
In order to express the recombinant subunit antigens (N-apxIV and C-apxIV) in the
host E. coli HMS147(DE3), IPTG w a s introduced into the growth culture. T w o
concentrations of IPTG, 0.5 m M and 2.0 m M , w a s used to determine whether there
was a difference in induction at these concentrations. Aliquots of bacterial growth
culture were taken at 0,1, 2 and 3 hours after the start of induction. The bacterial
pellets were loaded onto a S D S - P A G E gel and the polypeptide fingerprints
analyzed. A n 80 kDa subunit antigen corresponding to N-apxIV (Schaller et al.,
1999) w a s observed as a distinct band in the presence of IPTG at all time points,
except at 0 hours, the time of start of induction (fig. 4.2A). A Molecular Analyst
aided protein scan profile indicated that the amount of induced protein increased
with time when 2.0 m M IPTG was used (fig. 4.3). A distinct band corresponding to
a 96 kDa protein w a s observed after host E. coli expressing recombinant C-apxIV
(Schaller et al., 1999) was induced with 0.5 m M and 2.0 m M IPTG (fig. 4.2B). The
amount of induced protein increased from 0 hours to 1 hour, although there w a s no
gradual increase from 1 hour to 3 hours (fig. 4.3).
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Based on the scan profiles of IPTG-induced recombinant bacteria, it can be
calculated that the amount of induced recombinant C-apxIV and N-apxIV w a s 1 5 %
and 1 7 % respectively of total protein loaded onto each lane of the S D S - P A G E gel.
In the course of scaling up purification of recombinant proteins by Preparative
S D S - P A G E , about 5000 u.g of bacterial protein (equivalent to 100 m g wet weight of
induced bacteria) is normally loaded onto each preparative gel column. From this,
approximately 750 and 850 ng of recombinant C-apxIV and N-apxIV protein can be
recovered. For ELISA analysis, these recombinant antigens were further diluted in
coating buffer to afinalconcentration of about 2 (ig/ml.
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Figure 4.1 Effect of IPTG supplementation on growth of (A) host E. coli JM109 X-pir/pQE9, (B)
E.coli HMS147(DE3) expressing recombinant C-apxIV, and (C) E.coli H M S 1 4 7 (DE3) expressing
recombinant N-apxIV. Bacterial cells were grown in Luria broth (LB) supplemented with 50 ug/ml
ampicillin and growth monitored. Samples were read on a spectrophotometer at O D 650nm and the
values plotted. 2 m M IPTG w a s added to the growth culture at the start of log growth. Arrow
indicates the time of IPTG supplementation.
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Polypeptide analysis w a s carried out on E. coli JM109Xnir/pQE9 grown in the
absence and presence of 2 m M IPTG (figure not shown). Results showed no
difference in bands corresponding to 80 kDa and 96 kDa proteins in bacteria grown
under the two conditions. Furthermore, an immunoblot analysis was carried out on
E. coli H M S 1 4 7 (DE3) carrying the recombinant plasmids, the host strain E. coli
HMS147(DE3) (no plasmid), host E.coli JM109?.pir/pQE9 (His-tag plasmid control)
and A.pleuropneumoniae H S 5 4 (positive control) using serum from pigs challenged
with A. pleuropneumoniae serovar 7. The results did not reveal the presence of
bands corresponding to rApxIV proteins in A. pleuropneumoniae HS54, and in the
other two E. coli strains. Immunoreactive bands corresponding to the recombinant
ApxIV toxins were observed for the host E. coli H M S 147 (DE3) expressing the
recombinant toxins (fig. 4.4).
4.3.3 Purification of recombinant N-apxIV and C-apxIV subunit antigen by
Preparative S D S - P A G E method
Induced host E. coli cells were fractionated by the preparative SDS-PAGE method
as this method has been successfully used in the laboratory of Dr. J. Chin for
purification of other recombinant proteins. A 6 % polyacrylamide gel column was
used to resolve the protein bands. The E. coli cells were resolved into various
subunit antigens, including the 80 kDa N-ApxIV recombinant antigen in fractions
22-28 (fig. 4.5A). E. coli expressing the 96 kDa recombinant C-ApxIV was also
subjected to fractionation on a preparative S D S - P A G E column containing a 6 %
polyacrylamide gel. The fractionation of this E. coli strain yielded various subunit
antigens, including the 96 kDa recombinant antigen in fractions 34-40 (fig. 4.5B).
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4.3.4

Confirmation of presence of bands corresponding to the recombinant
subunit antigens by ELISA profiling

Recombinant subunit antigens N-ApxlV and C-ApxIV were purified from whole cell
E. coli by preparative S D S - P A G E method (section 4.2.1). Fractions were chosen
based on earlier results from section 4.3.3, and coupled onto ELISA plates. Serum
from pigs challenged with A. pleuropneumoniae serovar 7 w a s then used to react
against the recombinant antigen. Fractions that showed reactivity against the
antisera, as confirmed by horseradish peroxidase labeled goat anti-swine IgG
binding, were identified. Fractions 21-28, corresponding to presence of the
recombinant protein N-apxIV (fig. 4.6A), showed reactivity. ELISA profile of CapxIV is depicted in fig. 4.6B. Fractions 35-40, corresponding to presence of
recombinant protein C-ApxIV showed reactivity against the antisera.
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Figure 4.2 Polypeptide fingerprints after IPTG supplementation on host bacteria E. coli
HMS147(DE3) expressing the (A) 80 kDa recombinant N-apxIV and (B) 96 kDa recombinant CapxIV. Cells were induced with 0.5 m M and 2 m M IPTG and their growth monitored over time. At
times 0,1,2 and 3 hours, aliquots were taken and these were pelleted and after resuspension in
Laemmli reducing mix they were loaded onto an 8 % SDS-polyacrylamide gel. Loading was
standardized at 5 ^g protein per lane. Lane 1, molecular weight standards. Lane 2-5 represent 0.5
m M IPTG induction at times 0, 1, 3 and 5 hours respectively. Lane 6-9 represent 2.0 m M IPTG
induction at times 0,1, 3 and 5 hours respectively. Arrows represent the induced recombinant
subunit antigens.
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Figure 4.3 Scan profile of SDS-PAGE gel loaded with induced proteins. SDS-polyacrylamide gels
containing the protein bands as described in figs. 4.3A and 4.3B were scanned using a Bio-Rad
densitometer. The scans were profiled by Molecular Analyst software. Peaks corresponding to the
induced proteins were further profiled to approximate percentage-induced protein present in the
loaded sample. Figure shows the percentage induced protein present when E. coli HMS147(DE3)
expressing recombinant N-apxIV was induced with 0.5 m M IPTG (A), 2.0 m M IPTG(B) and E. coli
HMS147(DE3) expressing recombinant C-apxIV was induced with 0.5 m M IPTG (C), and 2.0 m M
IPTG(D).
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Figure 4.4 Immunoblot depicting the reactivity of pooled sera from pigs challenged with A.
pleuropneumoniae Sv 7(WF83) against an antigen panel consisting of A. pleuropneumoniae HS54,
E. coli JM109X.nir/pQE9 (host/plasmid control), E. coli HMS147(DE3)/pJFFapxlVA3Chis (C-ApxIV),
and E. coli HMS147(DE3)/pJFFapxlV1His2 (N-ApxIV) and (labeled 1, 2, 3 and 4 respectively). For
SDS-PAGE, the equivalent of 5 i_g protein w a s loaded onto each lane of a 1 2 % polyacrylamide
S D S gel with a 4 % stacking gel and the gel run under denaturing conditions (Laemmli, 1970). The
proteins were transferred electrophorically onto nitrocellulose. Pooled sera were added at a dilution
of 1/500 for 90 minutes. Antibodies were detected by the addition of goat anti pig serum at a dilution
of 1/1000. The immunoreactivity w a s visualized by the addition of 50 ul 2,2-azino bis (3
ethylbenzthiazoline-6-sulphonic acid) diammonium salt (ABTS). Arrows indicate the positions of
immunoreactive bands corresponding to the apparent molecular sizes of the recombinant toxin
antigens (Lanes 3 and 4).
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4.3.5 A s s e s s m e n t of immunoreactivity of recombinant C-apxIV and N-apxIV
against sera from infected pigs

To assess their utility as serological reagents, purified recombinant C-apxIV and
apxIV antigens were coupled to ELISA plates at a concentration of 2 u.g/ml (see
Section 4.3.2). The immunoreactivity of the purified recombinant antigens was
assessed by reacting the antigen against sera from 12 randomly selected healthy
piglets that had been brought into a commercial piggery with endemic
pleuropneumonia. Serum w a s collected at days 28, 60, 92 and 128 after
introduction into the piggery (fig. 4.7). For comparison, Apxl antigen (purified from
culture supernatants of nutrient-shocked cultures of A. pleuropneumoniae serovar
I) was also coupled to ELISA plates at 2 |ig/ml and these were assayed in parallel
with the ApxIV recombinant antigens. The data infig4.7 showed weak antibody
responses against the recombinant antigens at days 28 and 60 with increased
responses at days 92 and 128 (fig. 4.7A.B). Immune response against C-apxIV
(fig. 4.7A) w a s generally higher than those against N-apxIV (fig. 4.7B). The
immune response against hemolysin w a s more enhanced, being strong at day 28,
and increasing with time until day 92 (fig. 4.7C). O n e of the most important pieces
of information to deduce from this comparative ELISA data, is the differential
responses registered by individual pigs against Apxl, C-apxIV and N-apxIV
antigens. The individual pig responses are summarized in Table 4.3 where it can
be seen that while most animals responded well to Apxl, the antibody response
against C and N antigens varied between animals.
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Table 4.3. Differential reactivity of pig sera against recombinant C-ApxIV, N-ApxIV
and Apxl (hemolysin)(L= ELISA reactivity between 0.2 and 0.6; H = ELISA
reactivity higher than 0.6; N = ELISA reactivity less than 0.2)
Pig number

Against C-ApxIV

Against N-ApxIV

Against
hemolysin

1

L

L

H

2

H

L

H

3

H

H

H

4

H

H

H

5

H

L

H

6

N

N

H

7

H

N

H

8

N

N

H

9

H

H

H

10

L

H

H

11

N

N

H

12

N

N

H

Fraction 10 13 16 19 23 25 28 31 34 37 40 W C

M 80kDa

B
Fraction 10 13 16 19 22 25 28 31 34 37 40 43 46 W C

^96kDa

i
Figure 4.5 Resolution of subunit antigens of E. coli HMS147(DE3) expressing (A) recombinant NapxIV and (B) recombinant C-apxIV by S D S - P A G E gel. E. coli HMS147(DE3) containing the
recombinant plasmids was induced with 2 m M IPTG and samples taken at 3 hours after induction.
The samples (100 mg) were resuspended in 1 ml Laemmli's reducing mix and loaded onto 6 %
acrylamide preparative S D S - P A G E column. Every third fraction was run on an 8 % S D S
polyacrylamide gel and visualized by silver stain. Fraction numbers are indicated on top of each
lane. W C represents recombinant host E. coli whole cell extract. Arrowheads indicate the position of
the recombinant proteins.
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Figure 4.6 Identification of recombinant subunit antigens by ELISA. (A) ELISA profile of host E. coli
HMS147(DE3) to identify the recombinant N-apxIV in fractions collected after preparative S D S P A G E . Selected fractions were diluted to 2 ug/ml and coupled to ELISA plates. Immunoreactivity
was detected by standard ELISA using swine anti-A pleuropneumoniae sera. Swine IgG that
reacted with the recombinant N-apxIV w a s detected with HRP-conjugated goat anti-swine IgG. (B)
ELISA profile of host E. coli H M S 1 4 7 (DE3) to locate the recombinant C-apxIV in fractions collected
after preparative S D S - P A G E . Selectedfractionswere coupled to ELISA plates after diluting to 2
ug/ml. Immunoreactivity w a s detected by standard ELISA using swine anti-A pleuropneumoniae
sera. Swine IgG that reacted with the recombinant C-apxIV w a s detected with HRP-conjugated goat
anti-swine IgG. Serum from animals prior to challenge is labeled "pre" while serum obtained from
animals after challenge with A. pleuropneumoniae labeled "post".
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Figure 4.7 Antibody response against (A) recombinant C-apxIV, (B) recombinant N-apxIV and (C)
A. pleuropneumoniae hemolysin (Apxl) in exposed pigs in piggery with endemic pneumonia at day
28, day 60, day 92, and day 125 as assessed by standard ELISA. Preparative S D S - P A G E purified
recombinant N-apxIV (2ug/ml) and recombinant C-apxIV (2^g/ml) (section 4.3.3), as well as purified
hemolysin (2ug/ml), were coupled to ELISA plates as described in methods. The antigens were
then reacted against sera from pigs from a piggery with endemic pneumonia. Sera that reacted with
the antigens were then detected with HRP-conjugated goat anti-swine IgG. (I would like to
acknowledge the inputs of Dr. James Chin for providing the sera from the piggery and to Bernadette
Turner for contributing to some of the ELISA experiments).
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4.4 Discussion
There were two factors that m a d e it feasible to evaluate ApxIV toxin as an ELISA
reagent. Firstly, Schaller et al were able to demonstrate that sera from pigs
infected with various serovars of A. pleuropneumoniae, reacted in immunoblots
against the rAp4 toxin antigen. Therefore the ApxIV toxin, like the 39 kDa O M P
antigen, is a c o m m o n antigen and will detect sero-converted pigs that m a y have
become infected by any serovar of A. pleuropneumoniae. This is particularly
important in the field since the isolation, culture and serotyping of A.
pleuropneumoniae can be difficult and tedious. Secondly, Schaller et al had
successfully cloned both the C and N-terminal fragments of ApxIV in E. coli. This
meant that the purification of C-ApxIV (96kDa) and N-apxIV (80 kDa) could be
accomplished by preparative S D S - P A G E without introducing the risk of A.
pleuropneumoniae antigens contaminating the purified fractions. However, it was
necessary to demonstrate also that subunit antigens of E. coli origin with molecular
sizes corresponding with 96 and 80 kDa respectively, were not reactive against
sera from pigs exposed to A. pleuropneumoniae.
PCR fragments encoding the C and N-terminal coding sequences of apxIV had
previously been cloned by Schaller et al. (1999) into a derivative p E T plasmid
(pET14b, Novagen; fig. 4.8) to yield pJFFapxlVA1NaHis1 (N-terminal) and
pJFFapxlVA3Chis (C-terminal) respectively. These plasmids were sent to Dr. J.
Chin from Professor J. Frey as part of a collaborative program to develop an ApxIV
ELISA. Recombinant E. coli encoding these plasmids w a s cultured in media
containing 2 m M IPTG (isopropyl-p-D-thiogalactopyranoside) to induce the
production of rAp4. A s shown in fig. 4.1, addition of IPTG arrested the growth of
both recombinant clones with concomitant production of C-ApxIV (96 kDa) and NApxIV (80 kDa) antigens respectively (fig. 4.2).
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fig. 4.8 Schematic diagram of pET-14b. This plasmid carries an N-terminal His-tag® sequence
followed by a thrombin site and three cloning sites (A/del, Xho\, BamHI). Target genes are cloned in
pET plasmids under the control of lacZ promoter. Presence of bla coding sequence (3306-4463)
confers ampicillin (Ap) resistance (arrow). Origin of replication (OriR) is present at 2845bp.
(Adapted from Novagen p E T manual, 1998).

The immunoreactivity of C-ApxIV (96 kDa) and N-ApxIV (80 kDa) antigens were
confirmed in immunoblots using pooled sera from pigs challenged with A.
pleuropneumoniae serovar 1. The data in fig. 4.4 show that both recombinant antigens
(lanes 3 and 4) were immunoreactive whilst antigens from the E. coli host (lanes 1 and
2) were not. These results confirmed Schaller's recently published data (1999) and
permitted the purification of the two recombinant antigens by preparative S D S - P A G E .
The main reason for using a pET plasmid vector was to clone both the C-terminal and
N-terminal fragments of apxIV in frame with the his-tag site. This would allow for the
expression of fusion C or N-terminal ApxIV protein fragments bearing a C-terminal
histidine decamer and an N-terminal histidine hexamer respectively. Such his-tagged
fusion proteins can be purified by Ni-NTA chromatography. However, this protocol w a s
not used for the generation of purified C-ApxIV (96 kDa) and N-ApxIV (80 kDa) antigens
because of the need to elute his-tagged proteins from Ni affinity gels with high
concentrations of urea at a reduced pH. The residual urea content present in
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recombinant proteins purified in this way m a y interfere with direct binding of the antigen
to ELISA plates. Removal of urea by gel filtration or dialysis could dramatically alter the
ionic strength of the solution and hydrophobicity of the protein molecule, causing in situ
precipitation and aggregation of the recombinant antigen. Such preparations are difficult
to resolubilize and even if drastic conditions were to be used, would result in solvated
molecules with altered epitopes that m a y lose immunoreacitvity. Alternatively, these
altered proteins m a y be difficult to bind to the plastic surface because of differences in
zeta potential arising from the use of harsh solvating agents. These problems have
been bypassed in our laboratory through the use of denatured subunit antigens
prepared by preparative S D S - P A G E , that can be very easily coupled directly to ELISA
plates (Chin et al., 1996). W e used this procedure to successfully purify C-ApxIV (96
kDa) and N-ApxIV (80 kDa) antigens from IPTG-induced E. coli bearing
pJFFapxlVA3Chis (C-terminal) and pJFFapxlVA1NaHis1 (N-terminal) plasmids
respectively (figs. 4.5 and 4.6).
Fig. 4.7 shows the temporal ELISA response of pigs from a piggery with endemic
pleuropneumonia against S D S - P A G E purified C-ApxIV (fig. 4.7A) and N-ApxIV (fig.
4.7B) antigens. For comparison, their responses against Apxl toxin are also included
(fig. 4.7C). Pigs 6, 8 and 12 showed no immunoreactivity against either C-ApxIV or NApxIV antigen but reacted moderately well against Apxl (Table 4.3). This demonstrated
clearly that there are no cross-reactivities between antibodies directed against ApxIV
and that of Apxl. Apxl is constitutively expressed by A. pleuropneumoniae very early in
infection. It is therefore not surprising that bloods from ail pigs were immunoreactive by
60 d in comparison to a complete lack of reactivity at this time point against either CApxIV or N-ApxIV antigen. The delayed serological reactivity against ApxIV compared
to Apxl m a y be associated with continued proliferation of the pathogen in vivo and
sustained ApxIV antigen production in a successful clinical infection as compared to an
abortive infection where early colonization by the pathogen m a y have been arrested by
immunological responses. Another notable feature w a s the higher level of reactivity
seen in 8 out of 12 pigs against the C-ApxIV antigen compared to 4 out of 12 pigs for
the N-ApxIV antigen. It is likely from a consideration of the Apx toxin structure (fig. 1.1)
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that insertion of the N-terminal end within the target cell shields this epitope from the
immune system whilst the C-terminal, which protrudes from the cell, is highly "visible" to
the i m m u n e system. Consequently, there m a y be a greater disposition to generate
antibodies against C-terminal compared to N-terminal epitopes.
The use of recombinant C-ApxIV and N-ApxIV as possible ELISA reagents have
shown promising results. This is the very first time that this recombinant toxin
antigen has been trialed as a possible ELISA reagent, and therefore there are
undoubtedly m a n y issues that have not been addressed. The issues of sensitivity
as well as species-specificity have not been looked at, although results from this
work did s h o w the absence of cross- reactivity of the recombinant toxins against
pig sera positive to Apxl and vice-versa (fig. 4.7). It would be interesting to
observe h o w the recombinant ApxIV toxin cloned in its entirety would react in an
ELISA as compared to C-ApxIV and N-ApxIV. Further work needs to be done to
answer those questions. This work has laid a foundation for future work to follow.
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Chapter 5: Conclusion
The major conclusions arising from this work are summarized below:
The Preparative SDS-PAGE technology is extremely useful for the purification of
both outer membrane proteins and exocellular toxins of A. pleuropneumoniae.
Denatured antigens generated in this way can be used directly for coupling to
ELISA plates. Such antigens can be easily evaluated as ELISA reagents. The 39
kDa O M P of A. pleuropneumoniae

as well as the recombinant ApxIV toxin domains

were successfully purified and evaluated as ELISA reagents.
The 39 kDa OMP of A. pleuropneumoniae was demonstrated to be highly
immunoreactive in an ELISA test and can be used to monitor temporal serological
responses of pigs following experimental infection with A. pleuropneumoniae. The
precision, specificity and sensitivity of this antigen is currently being assessed.
The recombinant ApxIV toxin antigens appear to be of value in predicting the
clinical status of A. pleuropneumoniae

infected pigs. A correlation between ELISA

responses against either the C-ApxIV and N-ApxIV antigen and the severity of lung
pneumonia can be established once necropsies have been carried out on both
clinically affected and subclinical pigs in conjunction with serological data based on
the two recombinant antigens.
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